These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21586217)

  • 1. Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.
    Distler JH; Jordan S; Airo P; Alegre-Sancho JJ; Allanore Y; Balbir Gurman A; Caporali R; Caramaschi P; Carreira PE; Chizzolini C; Cutolo M; Tuncay Duruöz M; Farge-Bancel D; Hesselstrand R; Iannone F; De Keyser F; Kucharz EJ; Launay D; García de la Peña Lefebvre P; Lukacova O; Marasini B; Martinovic D; Marques Neto JF; Radic M; Rednic S; Riemekasten G; Rovensky J; Seidel MF; Senel S; Smith V; Sunderkötter C; Ton E; van Laar JM; Matucci-Cerinic M; Müller Ladner U; Distler O
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S40-5. PubMed ID: 21586217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
    Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of TNF-α inhibitors in systemic sclerosis.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Puppo F
    Immunotherapy; 2014; 6(3):283-9. PubMed ID: 24762073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis.
    Omair MA; Phumethum V; Johnson SR
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S55-9. PubMed ID: 22691210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
    Elhai M; Meunier M; Matucci-Cerinic M; Maurer B; Riemekasten G; Leturcq T; Pellerito R; Von Mühlen CA; Vacca A; Airo P; Bartoli F; Fiori G; Bokarewa M; Riccieri V; Becker M; Avouac J; Müller-Ladner U; Distler O; Allanore Y;
    Ann Rheum Dis; 2013 Jul; 72(7):1217-20. PubMed ID: 23253926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
    Avouac J; Huscher D; Furst DE; Opitz CF; Distler O; Allanore Y;
    Ann Rheum Dis; 2014 Jan; 73(1):191-7. PubMed ID: 23349131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
    Distler O; Behrens F; Pittrow D; Huscher D; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Furst DE;
    Arthritis Rheum; 2008 Jun; 59(6):867-75. PubMed ID: 18512721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.
    Coulter C; Baron M; Pope JE
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):24-30. PubMed ID: 23557780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
    Walker KM; Pope J; ;
    J Rheumatol; 2011 Jul; 38(7):1326-8. PubMed ID: 21459952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features.
    Hoffmann-Vold AM; Distler O; Murray B; Kowal-Bielecka O; Khanna D; Allanore Y;
    RMD Open; 2019; 5(1):e000826. PubMed ID: 30997150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
    Pellar RE; Pope JE
    Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
    Walker KM; Pope J; ;
    Semin Arthritis Rheum; 2012 Aug; 42(1):42-55. PubMed ID: 22464314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.
    Beyer C; Distler JH; Allanore Y; Aringer M; Avouac J; Czirják L; Cutolo M; Damjanov N; Del Galdo F; Fligelstone K; Guiducci S; Kowal-Bielecka O; van Laar JM; Martucci-Cerinic M; Müller-Ladner U; Riemekasten G; Tarner IH; Tyndall A; Kennedy AT; Valentini G; Vettori S; Walker UA; Denton C; Distler O;
    Ann Rheum Dis; 2011 Jul; 70(7):1178-82. PubMed ID: 21285118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE
    Ann Rheum Dis; 2009 Sep; 68(9):1377-80. PubMed ID: 19674983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.
    Fransen J; Johnson SR; van den Hoogen F; Baron M; Allanore Y; Carreira PE; Czirják L; Denton CP; Distler O; Furst DE; Gabrielli A; Herrick A; Inanc M; Kahaleh B; Kowal-Bielecka O; Medsger TA; Mueller-Ladner U; Riemekasten G; Sierakowski S; Valentini G; Veale D; Vonk MC; Walker U; Chung L; Clements PJ; Collier DH; Csuka ME; Jimenez S; Merkel PA; Seibold JR; Silver R; Steen V; Tyndall A; Matucci-Cerinic M; Pope JE; Khanna D
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):351-7. PubMed ID: 22052558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of infliximab in a patient with scleroderma: a case report.
    Li T; Liu Y; Xu H
    Medicine (Baltimore); 2017 Jun; 96(22):e6737. PubMed ID: 28562527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.